TransMedics TMDX
NASDAQ TMDX
$86.40 -1.87 (-2.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

TransMedics (TMDX) Net Margin Growth (3y) (2021 - 2026)

Analysis

TransMedics (TMDX) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -641.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 420.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 484.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 459.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 941.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -1,024.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 574.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 300.00
10 TransMedics 2.98 Bn 2.51 Bn 113.20 Mn 964.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 964.00
Mar 31, 2026 1,053.00
Dec 31, 2025 9,993.00
Sep 30, 2025 4,583.00
Jun 30, 2025 7,832.00
Mar 31, 2025 8,440.00
Dec 31, 2024 15,556.00
Sep 30, 2024 24,334.00
Jun 30, 2024 13,376.00
Mar 31, 2024 11,626.00
Dec 31, 2023 8,840.00
Sep 30, 2023 2,555.00
Jun 30, 2023 21,469.00
Mar 31, 2023 10,104.00
Dec 31, 2022 13,195.00
Sep 30, 2022 8,601.00
Jun 30, 2022 10,613.00
Mar 31, 2022 8,094.00
Dec 31, 2021 7,128.00
Sep 30, 2021 -11,307.00